...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability
【24h】

Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability

机译:活性炭作为无定形药物递送的载体:药物特征和载体润湿性的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Recent research on porous silica materials as drug carriers for amorphous and controlled drug delivery has shown promising results. However, due to contradictory literature reports on toxicity and high costs of production, it is important to explore alternative safe and inexpensive porous carriers. In this study, the potential of activated carbon (AC) as an amorphous drug carrier was investigated using paracetamol (PA) and ibuprofen (IBU) as model drugs. The solution impregnation method was used for drug loading, with loading efficiency determined by UV spectroscopy and drug release kinetics studied using USP II dissolution apparatus. The physical state of the drug in the complex was characterised using differential scanning calorimetry and X-ray diffractions techniques, whilst sites of drug adsorption were studied using Fourier transform infrared spectroscopy and N-2 adsorption techniques. In addition, the cytotoxicity of AC on human colon carcinoma (Caco-2) cells was assessed using the MIT assay. Results presented here reveal that, for PA/AC and IBU/AC complexes, the saturation solubility of the drug in the loading solvent appears to have an effect on the drug loading efficiency and the physical state of the drug loaded; whilst drug release kinetics were affected by the wettability of the activated carbon particles. Furthermore, activated carbon microparticles exhibited very low cytotoxicity on Caco-2 cells at the concentrations tested (10-800 mu g/mL). This study, therefore, supports the potential of activated carbon as a carrier for amorphous drug delivery. (C) 2017 Elsevier B.V. All rights reserved.
机译:最近对无定形和控制药物递送的药物载体的多孔二氧化硅材料的研究表明了有前途的结果。然而,由于矛盾的文献报告了有毒的毒性和生产成本高,重要的是探索替代安全和廉价的多孔载体。在该研究中,使用扑热酰胺(PA)和布洛芬(IBU)作为模型药物研究了活性炭(AC)作为非晶药物载体的潜力。溶液浸渍方法用于药物负载,通过使用USP II溶解装置研究的UV光谱和药物释放动力学测定的负载效率。使用差分扫描量热法和X射线衍射技术表征复合物中药物的物理状态,使用傅里叶变换红外光谱和N-2吸附技术研究药物吸附位点。此外,使用麻省理工学院测定评估AC对人结肠癌(Caco-2)细胞的细胞毒性。此处提出的结果表明,对于PA / Ac和IBU / AC复合物,药物在负载溶剂中的饱和溶解度似乎对药物负荷效率和负载药物的物理状态具有效果。虽然药物释放动力学受活性炭颗粒的润湿性的影响。此外,活性炭微粒在测试(10-800μmg/ ml)的浓度下在CaCO-2细胞上表现出非常低的细胞毒性。因此,该研究支持活性炭作为非晶药物递送的载体的潜力。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号